Biopharmas raising money in public or private financings, including: 180, Biostage, Calida, Immunogen, Recce.

Med-tech firms raising money in public or private financings, including: Celularity, Felix Health, G Medical Innovations, Occlutech.

Biopharmas raising money in public or private financings, including:  Addex, Celularity, Cellectis, Protagonist, Transcode.

Biopharmas in Asia-Pacific raising money in public or private financings: Salubris, Shenzhen Salubris.

Med-tech firms raising money in public or private financings, including: Chitogenx, Delcath, Neuronetics, Oncocyte.

Mercy Bioanalytics Inc. stepped into the increasingly competitive early cancer detection field with a $41 million series A financing round to support its Halo liquid biopsy platform. Novalis Lifesciences led the oversubscribed round with participation from Sozo Ventures, Hatteras Venture Partners, Iselect Fund, American Cancer Society BrightEdge and Broadway Angels, an all-women venture capital group. Laboratory Corp. of America Holdings, Bruker Corp. and existing investors also contributed to the round.

Adcendo ApS has added a further €31 million (US$33.6 million) to its series A round, providing the means to take its lead antibody-drug conjugate (ADC) through to clinical proof of concept in the treatment of sarcoma.

Biopharmas raising money in public or private financings, including: Cure Ventures, Diamond, Mosaic, OS Therapies, Psyence, Recce, Redhill, Viking.

Med-tech firms raising money in public or private financings, including: BBS, Bio-Techne, Mercy Bioanalytics, Wilson Wolf.